Pub Date : 2020-01-01DOI: 10.35841/cardiology.4.1.24-28
A. Sharma, R. Nath, N. Pandit
Introduction: Despite all available theoretical assumptions, there is no study defining the prevalence of lipid and lipoprotein abnormalities among siblings of young acute myocardial infarction (MI) patients. This is the first such study. Methods: This was a case-control study. A total 110 siblings of young acute MI patients (Group A) and 50 healthy young controls (Group B) were studied for a duration of 2 years. Clinical profiles included age, sex, smoking, hypertension, diabetes mellitus, abdominal obesity and dyslipidemia for both cases and controls.The primary objective was to study the prevalence of dyslipidemia and lipoprotein abnormalities. The secondary objective was to study the prevalence of conventional risk factors among siblings of young (<45 years) acute MI patients. Results: On analyzing lipid profiles, it was found that total cholesterol, triglycerides, low-density lipoprotein, ApoB100, ApoB100: ApoA-1 ratio, and lipoprotein (a) were significantly raised in Group A in comparison to Group B. On studying conventional risk factors, it was observed that history of smoking, hypertension, diabetes mellitus, and increased waist circumference were more prevalent in Group A in comparison to Group B. Conclusion: Conventional atherosclerotic risk factors, lipid and lipoprotein abnormalities were significantly more prevalent in siblings of young acute MI patients in comparison to healthy controls and may be an answer to the possible cause of familial clustering in young MI emphasizing the importance of familial screening. Therefore, intensive efforts should be made to identify and alter modifiable risk factors in these cases.
{"title":"To determine the prevalence of dyslipidemia and lipoprotein abnormalities among siblings of young acute myocardial infarction patients.","authors":"A. Sharma, R. Nath, N. Pandit","doi":"10.35841/cardiology.4.1.24-28","DOIUrl":"https://doi.org/10.35841/cardiology.4.1.24-28","url":null,"abstract":"Introduction: Despite all available theoretical assumptions, there is no study defining the prevalence of lipid and lipoprotein abnormalities among siblings of young acute myocardial infarction (MI) patients. This is the first such study. Methods: This was a case-control study. A total 110 siblings of young acute MI patients (Group A) and 50 healthy young controls (Group B) were studied for a duration of 2 years. Clinical profiles included age, sex, smoking, hypertension, diabetes mellitus, abdominal obesity and dyslipidemia for both cases and controls.The primary objective was to study the prevalence of dyslipidemia and lipoprotein abnormalities. The secondary objective was to study the prevalence of conventional risk factors among siblings of young (<45 years) acute MI patients. Results: On analyzing lipid profiles, it was found that total cholesterol, triglycerides, low-density lipoprotein, ApoB100, ApoB100: ApoA-1 ratio, and lipoprotein (a) were significantly raised in Group A in comparison to Group B. On studying conventional risk factors, it was observed that history of smoking, hypertension, diabetes mellitus, and increased waist circumference were more prevalent in Group A in comparison to Group B. Conclusion: Conventional atherosclerotic risk factors, lipid and lipoprotein abnormalities were significantly more prevalent in siblings of young acute MI patients in comparison to healthy controls and may be an answer to the possible cause of familial clustering in young MI emphasizing the importance of familial screening. Therefore, intensive efforts should be made to identify and alter modifiable risk factors in these cases.","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"20 1","pages":"24-28"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83691255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.4149/cardiol_2020_3_3
R. Hatala, I. Lazúrová
{"title":"Príspevok k aktuálnej diskusii o organizácii predoperačných vyšetrení pred elektívnou nekardiálnou chirurgiou v SR – pohľad kardiológa a internistu","authors":"R. Hatala, I. Lazúrová","doi":"10.4149/cardiol_2020_3_3","DOIUrl":"https://doi.org/10.4149/cardiol_2020_3_3","url":null,"abstract":"","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"180 1","pages":"135-137"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83010186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.4149/cardiol_2020_4_7
J. Murín, J. Bulas, M. Wavruch
{"title":"Je dôležité znížiť aj „Lipoproteín a“ [Lp(a)] pri sekundárnej prevencii kardiovaskulárnej morbidity a mortality? / Is it important to reduce serum levels of Lp(a) in secondary prevention of cardiovascular morbidity and mortality?","authors":"J. Murín, J. Bulas, M. Wavruch","doi":"10.4149/cardiol_2020_4_7","DOIUrl":"https://doi.org/10.4149/cardiol_2020_4_7","url":null,"abstract":"","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"6 1","pages":"240-242"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80238283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.4149/cardiol_2020_4_8
J. Payer
{"title":"Vplyv hypersekrécie rastového hormónu na kardiovaskulárny systém / Effect of growth hormone hypersecretion on the cardiovascular system","authors":"J. Payer","doi":"10.4149/cardiol_2020_4_8","DOIUrl":"https://doi.org/10.4149/cardiol_2020_4_8","url":null,"abstract":"","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"50 1","pages":"243-247"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84854576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.4149/cardiol_2020_3_2
D. Pella
{"title":"Komentár k odporúčaniam ESC/EAS z roku 2019 pre manažment dyslipidémií / Comment on 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias","authors":"D. Pella","doi":"10.4149/cardiol_2020_3_2","DOIUrl":"https://doi.org/10.4149/cardiol_2020_3_2","url":null,"abstract":"","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"72 1","pages":"131-134"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88537811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.4149/cardiol_2020_4_11
M. Luknár, P. Lesný, M. Svetlosak, P. Hlivák, E. Goncalvesová
{"title":"Supraventrikulárna tachykardia v kontexte idiopatickej pľúcnej artériovej hypertenzie / Supraventricular tachycardia in idiopathic pulmonary arterial hypertension","authors":"M. Luknár, P. Lesný, M. Svetlosak, P. Hlivák, E. Goncalvesová","doi":"10.4149/cardiol_2020_4_11","DOIUrl":"https://doi.org/10.4149/cardiol_2020_4_11","url":null,"abstract":"","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"28 1","pages":"259-266"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79417089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.35841/cardiology.4.1.48-50
B. Valdigem, H. Lopes, R. Tuma, Bruno Norm, Natália Massoni, Natasha Soares Simões dos Santos, A. Vilela, P IbraimFrancisco, J. Assef
Sars-COV2 usually has a flu-like condition with possible progression to lung involvement. Isolated cardiac involvement has a slight frequency and present as arrhythmias, pericarditis or myocarditis. This is a rare case of COVID-1 patient, without pulmonary involvement with pericarditis, pericardial effusion and focal left ventricular impaired contraction.
{"title":"COVID-19: Cardiovascular involvement without pulmonary signs.","authors":"B. Valdigem, H. Lopes, R. Tuma, Bruno Norm, Natália Massoni, Natasha Soares Simões dos Santos, A. Vilela, P IbraimFrancisco, J. Assef","doi":"10.35841/cardiology.4.1.48-50","DOIUrl":"https://doi.org/10.35841/cardiology.4.1.48-50","url":null,"abstract":"Sars-COV2 usually has a flu-like condition with possible progression to lung involvement. Isolated cardiac involvement has a slight frequency and present as arrhythmias, pericarditis or myocarditis. This is a rare case of COVID-1 patient, without pulmonary involvement with pericarditis, pericardial effusion and focal left ventricular impaired contraction.","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"43 1","pages":"48-50"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85817560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：